1. Home >
  2. Leica Biosystems Nussloch Acquires Kreatech Biotechnology BV

M&A Deal Summary

Leica Biosystems Nussloch Acquires Kreatech Biotechnology BV

On July 8, 2013, Leica Biosystems Nussloch acquired leisure company Kreatech Biotechnology BV

Acquisition Highlights
  • This is Leica Biosystems Nussloch’s 1st transaction in the Leisure sector.
  • This is Leica Biosystems Nussloch’s 1st transaction in the Netherlands.

M&A Deal Summary
Date 2013-07-08
Target Kreatech Biotechnology BV
Sector Leisure
Buyer(s) Leica Biosystems Nussloch
Deal Type Add-on Acquisition
Advisor(s) Achelous Partners (Financial)

Target

Kreatech Biotechnology BV

Amsterdam, Netherlands
Kreatech is a molecular diagnostics company focusing on the development and commercialization of innovative detection products.

Search 204,883 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Leica Biosystems Nussloch

Nussloch, Germany
Category Company
Sector Test/Measurement Equipment
DESCRIPTION

Leica Biosystems offers histopathology laboratories the most extensive product range with industry leading solutions for each workflow step, to enable the improvement of workflow efficiency and diagnostic confidence. The Company has manufacturing facilities in 7 countries, sales and service organizations in 19 countries, and an international network of dealers. Leica Biosystems is headquartered in Nussloch, Germany.

DEAL STATS #
Overall 2 of 4
Sector (Leisure) 1 of 1
Type (Add-on Acquisition) 2 of 4
Country (Netherlands) 1 of 1
Year (2013) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-24 Aperio Technologies

Vista, California, United States

Aperio Technologies, Inc. is a provider of ePathology solutions. Aperio products are transforming the practice of pathology in hospitals, reference labs, and pharmaceutical and research institutions around the world.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-02 Devicor Medical Products

Pleasant Prairie, Wisconsin, United States

Devicor Medical Products is a developing medical device businesses and products with a clinical preference. The Company owns the Mammotome breast care business which develops, manufactures and markets minimally invasive breast biopsy devices and accessories in over 40 countries worldwide. Devicor is led by CEO Tom Daulton.

Buy -
Mergr

Product

Company

Legal